News
Empowering the biopharma industry with field-leading foundation models.
Recent News
Press
|
April 26, 2021
AI 50 2021: America's Most Promising Artificial Intelligence Companies
Forbes
Press
|
December 2, 2020
Genesis Therapeutics Secures $52M Series A, Led by Rock Springs Capital
Business Wire
Press
|
December 2, 2020
Genesis Therapeutics raises $52M A round for its AI-focused drug discovery mission
TechCrunch
Press
|
July 3, 2020
AI 50 2020: America's Most Promising Artificial Intelligence Companies
Forbes
Presentations & Publications
|
April 14, 2020
Improvement in ADMET Prediction with Multitask Deep Featurization
Press
|
December 3, 2019
30 Under 30: Healthcare 2020
Forbes
Press
|
November 21, 2019
Genesis Therapeutics Raises $4.1M Seed, Led by Andreessen Horowitz
Business Wire
Presentations & Publications
|
November 2, 2018
PotentialNet for Molecular Property Prediction
Join Us
Opportunities in AI and Physics Research
Our molecular AI research team is pioneering new frameworks for drug discovery, at the intersection of multi-dimensional ML models and physical simulation. See opportunities in software engineering, machine learning and computation chemistry.
Software Engineering
Machine Learning
Computational Chemistry
